Deka Bank Deutsche Girozentrale Neogenomics Inc Transaction History

Deka Bank Deutsche Girozentrale

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$30.49 - $48.49 $1.55 Million - $2.46 Million	-50,800 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$41.66 - $52.52 $208,299 - $262,600	5,000 Added 10.92%	50,800 $2.48 Million
Q2 2021 Aug 05, 2021	BUY	$36.62 - $51.69 $695,780 - $982,110	19,000 Added 70.9%	45,800 $2.12 Million
Q1 2021 Apr 28, 2021	BUY	$41.56 - $59.88 $1.01 Million - $1.46 Million	24,300 Added 972.0%	26,800 $1.2 Million
Q4 2020 Mar 12, 2021	BUY	$36.08 - $56.47 $36,080 - $56,470	1,000 Added 66.67%	2,500 $132,000
Q3 2020 Oct 29, 2020	BUY	$33.26 - $40.48 $49,890 - $60,719	1,500 New	1,500 $55,000

282

124M

751K

107K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.24B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.